Soluble TNF receptor 1-secreting ex vivo-derived dendritic cells reduce injury after stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 9, 2013, Pages 1376-1385

  Works, Melissa G ^a   Koenig, Jenny B ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

acute stroke; cell tracking; chemokines; immunology; inflammation

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION;

ANIMALS; CELL MOVEMENT; DENDRITIC CELLS; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STROKE; TIME FACTORS;

EID: 84883743305     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.100     Document Type: Article

References (30)

1. Killer M, Ladurner G, Kunz AB, Kraus J. Current endovascular treatment of acute stroke and future aspects. Drug Discov Today 2010; 15: 640-647.
2. Lansberg MG, Bluhmki E, Thijs VN. Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke. Stroke 2009; 40: 2438-2441.
3. Manley NM, Caso JR, Works MG, Cutler AB, Zemlyak I, Sun G et al. Derivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured rat. PLoS One 2013; 8: e61789.
4. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007; 184: 53-57.
5. Liu T, Clark RK, McDonnel PC, Young PR, White RF, Barone FC et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-1488. (Pubitemid 24198599)
6. Buttini M, Sauter A, Boddeke NW. Induction of interleukin-1 beta mRNA after focal cerebral ischemia in the rat. Mol Brain Res 1994; 23: 126-134.
7. Davies CA, Loddick SA, Toulmond S, Stroemer PP, Hunt J, Rothwell NJ. The progression and topographic distribution of interleukin-1beta expression after permament middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1999; 19: 87-98. (Pubitemid 29283584)
8. Caso JR, Moro MA, Lorenzo P, Lizasoain I, Leza JC. Involvement of IL-1 beta in acute stress induces worsening of cerebral ischemia in rats. Eur J Neuropsychopharmacol 2007; 17: 600-607. (Pubitemid 47068933)
9. Yamagami S, Tamura M, Hayashi M, Endo N, Tanabe H, Katsuura Y et al. Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J Leukoc Biol 1999; 66: 744-749. (Pubitemid 29279521)
10. Nishi T, Maier CM, Hayashi T, Saito A, Chan PH. Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1a expression after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25: 1312-1324. (Pubitemid 41348733)
11. Offner H, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006; 26: 654-665.
12. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe C, Siler DA et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849-1857.
13. Kostulas N, Li H, Xiao B, Huang Y, Kostulas V, Link H. Dendritic cells are present in the ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 2002; 33: 1129-1134. (Pubitemid 34293602)
14. Belayev L, Alonsa OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture neurological and pathological evaluation of an improved model. Stroke 1996; 27: 1616-1623. (Pubitemid 26295914)
15. Grauer O, Wohlleben G, Seubert S, Weishaupt A, Kampgen E, Gold R. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique. Histochem Cell Biol 2002; 117: 351-362. (Pubitemid 34985041)
16. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267. (Pubitemid 26119138)
17. Xu X, Zhang S, Yan W, Li X, Zhang H, Zheng X. Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci 2006; 78: 704-712. (Pubitemid 41823938)
18. Fabry Z, Waldschmidt MM, Hendrickson D, Keiner J, Love-Homan L, Takei F et al. Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp55. J Neuroimmunol 1992; 36: 1-11.
19. Arjmandi A, Liu K, Dorovini-Zis K. Dendritic cell adhesion to cerebral endothelium: role of endothelial cells adhesion molecules and their ligands. J Neuropathol Exp Neurol 2009; 68: 300-313.
20. Zaremba J, Skrobanski P, Losy J. Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infaract. Biomed Pharmacother 2001; 55: 258-263. (Pubitemid 32595480)
21. Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL. Inhibition of TNF-alpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. NeuroReport 1998; 9: 2131-2134. (Pubitemid 28300580)
22. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol 1995; 268: H517-H525.
23. Vecchi A, Massimiliano L, Ramponi S, Luini W, Bernasconi S, Bonecchi R et al. Differential responsiveness to constitutive versus inducible chemokines of immature and mature mouse dendritic cells. J Leukoc Biol 1999; 66: 489-494. (Pubitemid 29439257)
24. Hallenbeck J. The many faces of tumor necrosis factor in stroke. Nat Med 2002; 8: 1363-1368. (Pubitemid 36019420)
25. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-1244. (Pubitemid 27248902)
26. Sumbria RK, Boado RJ, Pardridge WM. Brain protection from stroke with intravenous TNF-alpha decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab 2012; 32: 1933-1938.
27. Dumas TC, Sapolsky RM. Gene therapy against neurological insults: sparing neurons versus sparing function. Trends Neurosci 2001; 24: 695-700. (Pubitemid 33097535)
28. Machado LS, Sazonova IY, Kozak A, Wiley DC, El-Remessy AB, Ergul A et al. Minocycline and tissue-type plasminogen activator for stroke asssssment of interaction potential. Stroke 2009; 40: 3028-3033.
29. Chio C, Lin J, Chang M, Wang C, Kuo J, Yang C et al. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem 2010; 115: 921-929.
30. Wolman RL, Nussmeier NA, Aggarwal A, Kanchuger MS, Roach GW, Newman MF et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Stroke 1999; 30: 514-522. (Pubitemid 29115385)